NCT02004509View on ClinicalTrials.gov

Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

2,054

Participants

Timeline

Start Date

February 6, 2015

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Atrial Fibrillation
Interventions
DRUG

Anticoagulant

Anticoagulant treatment will be started in case of subclinical atrial fibrillation (\>5,5 hours per day) be diagnosed by cardiac implantable electronic device at intervention group, or clinical atrial fibrillation in both groups.

Trial Locations (1)

05403-900

RECRUITING

Martino Martinelli Filho, São Paulo

All Listed Sponsors
lead

InCor Heart Institute

OTHER